Edesa Biotech is trading 13.39% higher at $4.15 after-hours on October 8; no confirmed company-specific announcement explains the move. - It closed the regular session at $3.66, before a sharp extended-hours rebound. - The Nasdaq fell 1.22% amid a weak broader market, which does not explain the stock’s rise; the reason remains unclear.